Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 19.37M | 17.23M | 15.09M | 12.78M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 19.37M | 17.23M | 15.09M | 12.78M | |
| Cost of Revenue | 10.52M | 9.60M | 8.54M | 8.58M | |
| Gross Profit | 8.85M | 7.63M | 6.55M | 4.20M | |
| SG&A Expenses | 33.73M | 50.46M | 23.80M | 19.23M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 48.25M | 65.45M | 35.69M | 31.21M | |
| Operating Income | -28.88M | -48.21M | -20.60M | -18.43M | |
| Income Before Tax | -25.79M | -51.01M | -21.74M | -20.32M | |
| Income Tax Expenses | 33.00K | 102.00K | 18.00K | 7.00K | |
| Earnings from Continuing Operations | -25.83M | -51.11M | -21.76M | -20.32M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -942.00K | 250.00K | 439.00K | |
| Net Income | -25.83M | -52.05M | -21.51M | -19.88M | |
| EBIT | -28.88M | -48.21M | -20.60M | -18.43M | |
| EBITDA | -26.85M | -46.38M | -18.71M | -16.06M | |
| EPS Basic | -0.50 | -2.25 | -1.25 | -1.12 | |
| Normalized Basic EPS | -0.31 | -1.34 | -0.67 | -0.62 | |
| EPS Diluted | -0.50 | -2.25 | -1.25 | -1.12 | |
| Normalized Diluted EPS | -0.31 | -1.34 | -0.67 | -0.62 | |
| Average Basic Shares Outstanding | 51.30M | 24.58M | 19.89M | 19.89M | |
| Average Diluted Shares Outstanding | 51.30M | 24.58M | 19.89M | 19.89M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |